CN109007845A - 一种美颜保健兼备的制剂 - Google Patents
一种美颜保健兼备的制剂 Download PDFInfo
- Publication number
- CN109007845A CN109007845A CN201810188750.4A CN201810188750A CN109007845A CN 109007845 A CN109007845 A CN 109007845A CN 201810188750 A CN201810188750 A CN 201810188750A CN 109007845 A CN109007845 A CN 109007845A
- Authority
- CN
- China
- Prior art keywords
- collagen
- health care
- preparation
- parts
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims abstract description 44
- 102000008186 Collagen Human genes 0.000 claims abstract description 26
- 108010035532 Collagen Proteins 0.000 claims abstract description 26
- 229920001436 collagen Polymers 0.000 claims abstract description 25
- 241000169546 Lycium ruthenicum Species 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 8
- USDAQJSRGJCNNX-JJKGCWMISA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide;sulfuric acid Chemical compound OS(O)(=O)=O.NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO USDAQJSRGJCNNX-JJKGCWMISA-N 0.000 claims abstract description 6
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 8
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 8
- 229960002442 glucosamine Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000005864 Sulphur Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims 2
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 claims 1
- 238000004873 anchoring Methods 0.000 claims 1
- 210000002469 basement membrane Anatomy 0.000 claims 1
- 229960002849 glucosamine sulfate Drugs 0.000 claims 1
- 229940099148 glucosamine sulfate potassium chloride Drugs 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 108700005457 microfibrillar Proteins 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 12
- 230000003712 anti-aging effect Effects 0.000 abstract description 7
- 230000002929 anti-fatigue Effects 0.000 abstract description 6
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000007661 gastrointestinal function Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000006210 lotion Substances 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- 239000001301 oxygen Substances 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000009759 skin aging Effects 0.000 abstract description 2
- 230000003349 osteoarthritic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229930014669 anthocyanidin Natural products 0.000 description 6
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 6
- 235000008758 anthocyanidins Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 230000009758 senescence Effects 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 210000003321 cartilage cell Anatomy 0.000 description 4
- 210000000282 nail Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 210000001188 articular cartilage Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- -1 cystine Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 231100000636 lethal dose Toxicity 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000004263 amino monosaccharides Chemical class 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical class OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 102000055008 Matrilin Proteins Human genes 0.000 description 1
- 108010072582 Matrilin Proteins Proteins 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000872198 Serjania polyphylla Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000294142 Vascellum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000003483 aging Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明涉及一种美颜保健兼备的制剂。属于保健食品领域。所述美颜保健制剂包括以下组分:氨基葡萄糖硫酸盐、二甲基砜、胶原蛋白、三七粉、黑枸杞。本发明可减缓骨关节炎症,改善骨关节健康、延缓衰老、美容养颜、抗疲劳、改善胃肠功能、调节血压等保健功能。能消除由氧自由基造成的人体衰老、皮肤老化、免疫力下降、疲劳、胃肠功能不调、胶原不足等症状。
Description
技术领域
本发明属于医药、保健食品领域,涉及一种美颜保健兼备的制剂。
背景技术
每个人都希望自己有一副靓丽的容颜和健康的体魄。作为人体基本组成单位的细胞,每天约有十分之七的细胞老化衰老,如新陈代谢完全正常,每天有相应的数量新生细胞产生。随着年龄增长,新生细胞达不到衰老细胞的数量,衰老的细胞促使各器官和组织也逐渐老化,这是自然规律。
如能使细胞老化延缓,就等于延缓衰老,减少各种疾病症状。抗氧自由剂是哺乳动物寿命决定因子,体内抗氧剂的水平与人类寿命有高度的正相关性,随着年龄的增长,人体拥有的抗氧剂已远远不能满足要求,要想细胞老化延缓必须从外界补充抗氧剂,以最大限度地清除抗氧自由基的毒性效应,抗氧剂是延缓衰老预防疾病的减速剂。
二甲基砜(MSM)是一种有机硫化物,是人体胶原蛋白合成的必要物质。在人的皮肤、头发、指甲、骨骼、肌肉和各器官中都含有二甲基砜,是人体中胱氨酸等含硫氨基酸、谷胱甘肽抗氧剂、胶原蛋白、胰岛素、皮肤、软骨、连接液、毛发、指甲、牙齿、骨骼、肌肉腱等器官组织中硫的主要来源。人体每天要消耗0.5mg二甲基砜,一旦缺乏就会引起健康失调或发生疾病。
二甲基砜(MSM)在生物中存在,在鱼、海产品、禽、肉、蛋、奶、水果、蔬菜、茶、咖啡等人类的食物和饮料中均会有相当数量。这些食物提供人们所需的二甲基砜,但由于二甲基砜易挥发,食物在贮运和热加工(煎、煮、炒、蒸等)过程,二甲基砜损失严重,某些人群无法从食物获得足够的二甲基砜和其它供硫化合物,使得含硫的氨基酸、肽、胶原蛋白不足,从而引起了衰老、疲劳、毛发脱落、指甲有裂痕、过敏、气喘、关节炎、胃肠有炎症、伤口难于愈合、便秘、腹泻、记忆力下降、免疫力下降、产生痤疮以及癌变等不同的病变。所以补充服用二甲基砜对人的身体是有促进保健作用的,因此,国外作为保健药品大量应用。
二甲基砜(MSM)在生物体内的毒性类似于水。半致死量LD 50大于20g/kg。也就是对体重75kg 的成年人,其半致死量相当于1500g,因此可以认为是无毒物。曾给百名人员试验,每日口服2g二甲基砜数年,未发现任何毒性,所以服用二甲基砜(MSM)是安全的。
二甲基砜(MSM)的原料二甲基亚砜的半致死量LD 50为18g/Kg,也属无毒物。曾对年龄18~30 岁健康男性,在10日内每天给予5ml(10份二甲基亚砜+10份二甲基砜)混合液,每天四次口服。每天进行两次标准血液学和生化试验(包括肝和尿功能试验,血糖、血清和血气),每天检测尿。并由电子心动图来判断心酶水平。试验表明无毒或任何不利现象。
胶原蛋白是动物结缔组织中的主要成分,也是哺乳动物体内含量最多、分布最广的功能性蛋白,占蛋白质总量的25份~30份,某些生物体甚至高达80份以上。畜禽源动物组织是人们获取天然胶原蛋白及其胶原肽的主要途径,胶原蛋白因具有良好的生物相容性、可生物降解性以及生物活性,因此在食品、医药、组织工程、化妆品等领域获得广泛的应用。
氨基葡萄糖是一种天然氨基单糖的衍生物,是软骨基质中合成蛋白聚糖所必需的重要成分。蛋白聚糖可以通过抑制胶原纤维的拉伸力来使关节软骨具有吸收冲击力的功能。在关节退行性疾病的早期,聚集葡萄聚糖的生物合成是增加的,在疾病的后期,则相反。由此导致软骨的弹性不断减弱并逐渐出现关节炎的诸多症状。氨基单糖可刺激软骨细胞产生具有正常多聚体结构的糖蛋白,抑制一些可损害关节软骨的酶(如胶原酶),防止皮质激素及某些非甾体抗炎药物对软骨细胞的损害及减少损伤细胞的内毒素因子的释放。在关节炎的发展进程中,补充外源性的氨基葡萄糖可能起到有益的作用。在体外试验中,如果补充了氨基葡萄糖,形成软骨的多形细胞就可以合成更多的聚集葡萄聚糖。在关节炎的动物模型中,氨基葡萄糖也具有抗氧化作用,抑制损伤细胞的超氧化物自由基的产生。通过上述途径,氨基葡萄糖发挥直接抗炎作用,可缓解骨关节炎的疼痛症状,改善关节功能,并可阻止骨关节炎病程的发展。
三七粉的成分和三七主根一样,富含三七皂苷、三七多糖、三七素、黄酮有效成分,具有止血、活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血压、提高机体免疫功能等作用。可用于治疗外伤出血、瘀血、胃出血、尿血等各种内、外出血症;扩张血管,溶解血栓,改善微循环,预防和治疗高血脂、胆固醇增高、冠心病、心绞痛、脑溢血后遗症等心脑血管疾病;脂肪肝、肝纤维化等肝病以及失血、产后、久病等原因导致的体虚症。
黑枸杞:抗衰老黑枸杞是最主要的功效之一,大量的花青素能够很好的抗氧化,消除人体自由基,具有显著的抗衰老的作用。花青素能穿越血脑屏障,可保护脑神经不被氧化,能稳定脑组织功能,保护大脑不受有害化学物质和毒素的伤害。食用黑枸杞中的花青素后,睡眠质量能得到显著提高。可防止皮肤皱纹的提早生成,使肌肤更年轻、更有活力。它不但能防止皮肤皱纹的提早生成,更能补充营养及消除体内有害的自由基。美容养颜、改善皮肤。
黑枸杞同红枸杞一样能够补肾益精,黑枸杞中的花青素(Anthocyanosides)有清除自由基的功效,花青素还能够改善血液循环,恢复失去的微血管功效,加强脆弱的血管,因而是血管更具弹性。原花青素被称为“动脉粥样硬化的解毒药”。黑果枸杞还可防治糖尿病,并具有明显的抗疲劳,保肝,还能抗肿瘤,疏通血管,降压,保护心血管系统作用。
发明内容
本发明涉及一种美颜保健兼备的制剂,其目的是提供一种使用安全、无副作用,能明显改善人骨关节健康、延缓衰老、美容养颜、抗疲劳、改善胃肠功能、调节血压等保健功能的医药、保健食品。其组分为:氨基葡萄糖硫酸盐、二甲基砜(MSM)、胶原蛋白、三七粉、黑枸杞。
本发明利用二甲基砜(MSM)能消除病毒、加强血液循环、软化组织、治疗关节炎、减轻痛苦、强筋壮骨、镇定安神、增强体力、促进皮肤、指甲、头发、骨胳、肌腱、和器官的健康,保养皮肤美发美容的功能。加上胶原蛋白与氨基葡萄糖的协同针对为关节软骨提供全面足够的营养,胶原蛋白滋补保健作用,有利于软骨细胞的复制与再生,有利于炎症的消除,加速骨关节运动机能的恢复。辅以三七活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血压、提高机体免疫功能等作用。同时采用具有较强功能的抗氧化物质原黑枸杞中富含的花青素,消除自由基,去除自由基给关节组织和软骨细胞所造成的损伤,防止皮肤皱纹的提早生成,使肌肤更年轻、更有活力。美容养颜、改善皮肤。组分之间产生了协同增效效果,提高产品营养效价。从而达到改善骨关节健康、延缓衰老、美容养颜、抗疲劳、改善胃肠功能、调节血压等保健的功能。消除由氧自由基造成的人体衰老、皮肤老化、免疫力下降、疲劳、胃肠功能不调、胶原不足等症状。
具体实施方式
本发明一种美颜保健兼备的制剂,采用的具体实施方案:按重量份计其组份氨基葡萄糖硫酸盐10 -60份、二甲基砜10-80份、胶原蛋白10-50份、三七粉0-50份、黑枸杞10-70份
各组份粉碎成细粉末,按比例搅拌均匀,装入胶囊的为胶囊型,压片制为片剂型。
一种美颜保健兼备的制剂,优选实施方案:按重量份计其组份氨基葡萄糖硫酸盐30-40份、二甲基砜50-70份、胶原蛋白20-30份、三七粉20-30份、黑枸杞30-60份。
一种美颜保健兼备的制剂,最优选实施方案:按重量份计其组份氨基葡萄糖硫酸盐40份、二甲基砜60份、胶原蛋白25份、三七粉25份、黑枸杞50份。
具体步骤:胶囊在室温低于25℃配制,配制前要将氨基葡萄糖硫酸盐、二甲基砜、胶原蛋白、三七粉、黑枸杞粉碎成细粉,然后按上述比例将所有物料加入混料机混合均匀,将混合好的物料装入胶囊,或压成片,每粒(片)500mg-1000mg。所用原料均为食品级,操作需在无菌环境中进行。
建议用量:每日三次,开始每次1-2粒,视服用情况可适当增减。
Claims (6)
1.一种美颜保健兼备的制剂,所述美颜保健品包括以下组分:氨基葡萄糖硫酸盐、二甲基砜、胶原蛋白、三七粉、黑枸杞。
2.根据权利要求1所述的一种美颜保健兼备的制剂,按重量份计其组份:氨基葡萄糖硫酸盐10-60份、二甲基砜10-80份、胶原蛋白10-50份、三七粉0-50份、黑枸杞10-70份。
3.根据权利要求1所述的一种美颜保健兼备的制剂,其特征在于氨基葡萄糖硫酸盐,可以是氨基葡萄糖硫酸钾盐;也可以是氨基葡萄糖硫酸钠盐。二甲基砜可以是食品级的,也可以是医药级的。胶原蛋白可以是纤维胶原、基膜胶原、微纤维胶原、锚定胶原、六边网状胶原、非纤维胶原、跨膜胶原等。包括类型为I型、II型、III型、V型和XI型。
4.根据权利要求1-2所述的一种美颜保健兼备的制剂,其特征在于三七、黑枸杞为干品,需要粉碎成粉末状。
5.根据权利要求1-4所述的一种美颜保健兼备的制剂,其特征在于各组份粉碎成细粉末,按比例搅拌均匀,装入胶囊的为胶囊型,压片制成为片剂型。
6.权利要求1-5所述的一种美颜保健兼备的制剂在制备食品或保健品或药品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810188750.4A CN109007845A (zh) | 2018-02-27 | 2018-02-27 | 一种美颜保健兼备的制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810188750.4A CN109007845A (zh) | 2018-02-27 | 2018-02-27 | 一种美颜保健兼备的制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109007845A true CN109007845A (zh) | 2018-12-18 |
Family
ID=64630268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810188750.4A Pending CN109007845A (zh) | 2018-02-27 | 2018-02-27 | 一种美颜保健兼备的制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109007845A (zh) |
-
2018
- 2018-02-27 CN CN201810188750.4A patent/CN109007845A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7799348B2 (en) | Therapeutic composition comprising hyaluronic acid and chondroitin sulfate and method of making same | |
US20090325885A1 (en) | Composition for acceleration of type i collagen production | |
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN108271982A (zh) | 一种鱼胶原蛋白肽植物固体饮料及其制备方法与应用 | |
CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
KR20170130968A (ko) | 저분자 콜라겐 펩티드 및 이를 이용한 식품 조성물의 제조 방법 | |
CN108813246A (zh) | 一种易吸收防流失的胶原蛋白肽抗衰组合物及其制备工艺 | |
CN111467481A (zh) | 一种改善和/或预防骨关节炎的组合物及其应用 | |
CN109601680A (zh) | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
KR20080090808A (ko) | 피부미용을 위한 건강보조식품의 조성물 | |
CN114365850A (zh) | 一种具有改善软骨健康的多肽组合物及其制备方法 | |
CN109464651A (zh) | 一种软骨代谢异常疾病改善用健康食品及药品组合物 | |
CN106174286A (zh) | 高级金枸杞营养果酱 | |
CA2607267A1 (en) | Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage | |
CN101297705B (zh) | 复方藏羊胎素祛皱抗衰胶囊 | |
CN114698850A (zh) | 一种蛋膜肽组合物的配方及制作方法 | |
CN108815505A (zh) | 提高中老年人骨密度和骨关节功能避免腰腿抽筋的组合物 | |
CN104839704A (zh) | 壮阳非全营养配方食品 | |
CN109007845A (zh) | 一种美颜保健兼备的制剂 | |
KR100870063B1 (ko) | 콜라겐 비타 유자청 조성물 및 그 제조방법 | |
CN108635618B (zh) | 一种具有促进愈合以及修复功能医用胶的制备方法 | |
CN105687714A (zh) | 一种美容养颜保健品 | |
RU2668338C1 (ru) | Способ производства обогащенных коллагеном питьевых киселей для функционального питания | |
CN108991358A (zh) | 一种辅助降血脂、降血糖、缓解痛风保健食品及生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181218 |
|
WD01 | Invention patent application deemed withdrawn after publication |